Alfentanil Intravenous and Carbamazepine Extended-Release Capsules (Equetro)
Determining the interaction of Alfentanil Intravenous and Carbamazepine Extended-Release Capsules (Equetro) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:CarBAMazepine may reduce the blood levels and effects of alfentanil. If you are currently being treated or have recently been treated with carBAMazepine, you may require a higher dosage to achieve adequate response to alfentanil. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with inducers of CYP450 3A4 may decrease the plasma concentrations of alfentanil, which appears to be extensively metabolized by the isoenzyme. Clinical data are limited, however. In nine healthy male volunteers, intravenous administration of a single 20 mcg/kg dose of alfentanil with the potent CYP450 3A4 inducer rifampin increased alfentanil clearance by nearly 3-fold and decreased elimination half-life by 40% compared to controls. Another study also reported substantially increased clearance rates of alfentanil in seven patients receiving long-term therapy with inducer drugs compared to six patients not receiving those drugs (mean clearance 6.94 mL/min/kg vs. 3.47 mL/min/kg; half-life 50.6 hrs vs. 90.7 hrs).
MANAGEMENT: Patients who are currently receiving or have recently received drugs that induce CYP450 3A4 should be monitored for potentially decreased response to alfentanil, and the dosage adjusted as necessary.
- Kharasch ED, Russell M, Mautz D, Thummel KE, Kunze KL, Bowdle A, Cox K "The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions." Anesthesiology 87 (1997): 36-50
- Koehntop DE, Noormohamed SE, Fletcher CV "Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation." Pharmacotherapy 14 (1994): 592-9
- Labroo RB, Thummel KE, Kunze KL, Podoll T, Trager WF, Kharasch ED "Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism." Drug Metab Dispos 23 (1995): 490-6
- Kharasch ED, Thummel KE "Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?" Anesth Analg 76 (1993): 1033-9
Generic Name: alfentanil
Brand name:
Synonyms: Alfentanil (Intravenous)
Generic Name: carbamazepine
Brand name: Carbatrol, Epitol, Equetro, Tegretol, Tegretol XR, Tegretol, Tegretol XR
Synonyms: Carbamazepine, CarBAMazepine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alfentanil Intravenous-Carbamazepine Extended-Release Tablets
- Alfentanil Intravenous-Carbamazepine Intravenous
- Alfentanil Intravenous-Carbamazepine Oral Suspension
- Alfentanil Intravenous-Carbamazepine Tablets
- Alfentanil Intravenous-Carbaphen 12
- Alfentanil Intravenous-Carbaphen CH
- Carbamazepine Extended-Release Capsules (Equetro)-Alferon N
- Carbamazepine Extended-Release Capsules (Equetro)-Alfuzosin
- Carbamazepine Extended-Release Capsules (Equetro)-Alfuzosin Hydrochloride
- Carbamazepine Extended-Release Capsules (Equetro)-Alfuzosin Tablets
- Carbamazepine Extended-Release Capsules (Equetro)-Ali-Flex Tablets
- Carbamazepine Extended-Release Capsules (Equetro)-Aliclen Shampoo